Wein Matthew bought MGX
April 1, 2026 · Form 4 insider transaction
Wein Matthew bought 68,000 shares of Metagenomi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
68,000
Price
$0.00
Total value
N/A
InsiderWein Matthew
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after68,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.